NAS:ALLO (USA)
Allogene Therapeutics Inc $ 34.00 1.535 (4.84%)
Volume:
933,725
Avg Vol (1m):
843,097
Market Cap $:
4.78 Bil
Enterprise Value $:
4.00 Bil
PE Ratio:
0.00
PB Ratio:
4.09
Financial Strength | 5/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | 15.39 | ||
Debt-to-Equity | 0.05 | ||
Debt-to-EBITDA | -0.22 | ||
Piotroski F-Score | 2 | ||
Altman Z-Score | 0 | ||
Beneish M-Score | 0 | ||
WACC vs ROIC |
Profitability Rank | 1/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
ROE % | -27.21 | ||
ROA % | -24.46 | ||
ROC (Joel Greenblatt) % | -194.72 |
ALLO
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 4.09 | ||
EV-to-EBIT | -16 | ||
EV-to-EBITDA | -16.52 | ||
Current Ratio | 8.96 | ||
Quick Ratio | 8.96 |
Dividend & Buy Back |
Current | Vs Industry | Vs History |
---|
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 4.09 | ||
Earnings Yield (Greenblatt) % | -6.28 |